Annual Retained Earnings:
-$1.43B-$463.66M(-47.92%)Summary
- As of today, RXRX annual retained earnings is -$1.43 billion, with the most recent change of -$463.66 million (-47.92%) on December 31, 2024.
- During the last 3 years, RXRX annual retained earnings has fallen by -$1.03 billion (-257.75%).
- RXRX annual retained earnings is now -1030.60% below its all-time high of -$126.59 million, reached on December 31, 2019.
Performance
RXRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$1.97B-$162.29M(-8.99%)Summary
- As of today, RXRX quarterly retained earnings is -$1.97 billion, with the most recent change of -$162.29 million (-8.99%) on September 30, 2025.
- Over the past year, RXRX quarterly retained earnings has dropped by -$715.50 million (-57.13%).
- RXRX quarterly retained earnings is now -821.29% below its all-time high of -$213.60 million, reached on December 1, 2020.
Performance
RXRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RXRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -47.9% | -57.1% |
| 3Y3 Years | -257.8% | -238.1% |
| 5Y5 Years | -1030.6% | - |
RXRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -257.8% | at low | -238.1% | at low |
| 5Y | 5-Year | -1030.6% | at low | -821.3% | at low |
| All-Time | All-Time | -1030.6% | at low | -821.3% | at low |
RXRX Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -$1.97B(-9.0%) |
| Jun 2025 | - | -$1.81B(-10.5%) |
| Mar 2025 | - | -$1.63B(-14.1%) |
| Dec 2024 | -$1.43B(-47.9%) | -$1.43B(-14.3%) |
| Sep 2024 | - | -$1.25B(-8.3%) |
| Jun 2024 | - | -$1.16B(-9.2%) |
| Mar 2024 | - | -$1.06B(-9.4%) |
| Dec 2023 | -$967.62M(-51.3%) | -$967.62M(-10.6%) |
| Sep 2023 | - | -$874.63M(-11.9%) |
| Jun 2023 | - | -$781.61M(-10.9%) |
| Mar 2023 | - | -$704.88M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$639.56M(-59.9%) | -$639.56M(-9.9%) |
| Sep 2022 | - | -$582.06M(-11.6%) |
| Jun 2022 | - | -$521.62M(-14.4%) |
| Mar 2022 | - | -$456.06M(-14.0%) |
| Dec 2021 | -$400.08M(-87.3%) | -$400.08M(-19.4%) |
| Sep 2021 | - | -$335.15M(-16.5%) |
| Jun 2021 | - | -$287.72M(-17.8%) |
| Mar 2021 | - | -$244.32M(-14.4%) |
| Dec 2020 | -$213.60M(-68.7%) | - |
| Dec 2020 | - | -$213.60M |
| Dec 2019 | -$126.59M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of RXRX is -$1.43B
What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual retained earnings is -$126.59M
What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, RXRX annual retained earnings has changed by -$463.66M (-47.92%)
What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of RXRX is -$1.97B
What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$213.60M
What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, RXRX quarterly retained earnings has changed by -$715.50M (-57.13%)